Bio-Techne (TECH) Invested Capital (2016 - 2023)

Bio-Techne's Invested Capital history runs 8 years deep, the most recent figure standing at $1.8 million for Q3 2023.

• On a quarterly basis, Invested Capital fell 76.35% year-over-year to $1.8 million in Q3 2023; TTM through Jun 2024 was $1.8 million, a 89.16% decrease from a year earlier, with the FY2023 full-year figure at $3.5 million, down 72.0% from the prior year.
• Invested Capital retreated to $1.8 million in Q3 2023 per TECH's latest filing, from $3.5 million in the prior quarter.
• Across five years, Invested Capital topped out at $12.5 million in Q3 2019 and bottomed at $1.8 million in Q3 2023.
• The 5-year median for Invested Capital is $5.6 million (2020), against an average of $7.5 million.
• Across the five-year window, Invested Capital surged 267.65% in 2020 and plunged 76.35% in 2023, its largest moves.
• Year by year, Invested Capital stood at $12.5 million in 2019, then plunged by 60.14% to $5.0 million in 2020, then slumped by 59.86% to $2.0 million in 2021, then soared by 270.0% to $7.4 million in 2022, then plunged by 76.35% to $1.8 million in 2023.
• Per Business Quant, the three latest TECH Invested Capital figures stand at $1.8 million (Q3 2023), $3.5 million (Q2 2023), and $5.2 million (Q1 2023).